AstraZeneca Annual Report and Form 20-F Information 2008

Notes to the Financial Statements (Company)

3 Loans

	Repayments dates	2008 $m	2007 $m
Amounts due within one year Interest bearing loans and borrowings (unsecured) US dollars
Floating Rate Note	2009	650	–
Amounts due after more than one year Amounts owed to subsidiaries (unsecured) US dollars
7.2% Loan	2023	283	283
Interest bearing loans and borrowings (unsecured) US dollars
Floating Rate Note	2009	–	649
5.4% Callable bond	2012	1,742	1,741
5.4% Callable bond	2014	748	747
5.9% Callable bond	2017	1,742	1,741
6.45% Callable bond	2037	2,716	2,715
Euros
4.625% Non-callable bond	2010	1,053	1,099
5.625% Non-callable bond	2010	702	–
5.125% Non-callable bond	2015	1,051	1,099
Pounds sterling
5.75% Non-callable bond	2031	501	691
		10,255	10,482
Loans or instalments thereof are repayable:
After five years from balance sheet date		7,041	7,276
From two to five years		1,742	2,840
From one to two years		1,755	649
Within one year		650	–
Total unsecured		11,188	10,765

With the exception of the floating rate note, all loans are at fixed interest rates. Accordingly the fair values of the loans will change as market rates change. However, since the loans are held at amortised cost, changes in interest rates and the credit rating of the Company do not have any effect on the Company’s net assets.

Back to the top